Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet medical needs, today announced that the U.S. Food and Drug Administration ...
Dr. Koneru has extensive experience and expertise in the field of drug development with a track record of advancing novel therapeutics from early development through later-stage clinical programs. She ...
The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback